Emanuel Husu, MD
Pain Medicine · Houston, TXNPI 1982967675
Payments from drug & device makers
Across 144 payments — averaging $81.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Si-bone, Inc.$1K
- Abbott$978
- Stryker$884
- SPR Therapeutics, Inc$621
- Nevro Corp.$334
- plus $1K from 11 others
What the payments were for
- Travel & lodging$6,62456%
- Food & beverage$5,17744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 76 | $6,424 |
| Si-bone, Inc. | 8 | $1,066 |
| Abbott | 12 | $978 |
| Stryker | 8 | $884 |
| SPR Therapeutics, Inc | 8 | $621 |
| Nevro Corp. | 5 | $334 |
| Stimwave Technologies Incorporated | 4 | $291 |
| Boston Scientific | 5 | $281 |
| GRT US Holding, Inc. | 4 | $209 |
| Curonix LLC | 2 | $194 |
| AbbVie | 3 | $170 |
| Relievant Medsystems, Inc. | 1 | $149 |
| Avanos Medical | 1 | $79 |
| Radius Health, Inc. | 3 | $61 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Sonex Health, Inc. | 1 | $11 |
| Hydrocision, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,968
- KYPHON EXPRESS II KYPHOPAK TRAY$1,412
- IFUSE IMPLANT SYSTEM$848
- INTELLIS ADAPTIVESTIM$740
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$521
- PROCLAIM$469
- Intracept$299
- SPRINT PNS System$264
- SPINEJACK$247
- OPTABLATE$247
- PRODIGY$193
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$169
- Senza Spinal Cord Stimulation System$125
- WaveWriter Alpha Prime 16$121
- Omnia$111
- INCEPTIV$109
How this compares
$11,802 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 11 | $3,126 |
| Gabapentin | 111 | $2,302 |
| Pregabalin | 40 | $1,873 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,193 |
| Duloxetine Hcl | 46 | $1,044 |
| Baclofen | 37 | $838 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $328 |
| Methocarbamol | 22 | $307 |
| Topiramate | 23 | $192 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Houston
- Mitchell EngleHouston$1.5M
- Daniel PakHouston$460K
- David LeimanHouston$281K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$161K
- Mayur KanjiaHouston$46K
- Baominh VinhHouston$44K
- Matthew ChungHouston$26K
- Aaron CalodneyTyler$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.